Global Markets

Zealand Pharma (ZEAL DC) targets 10 new clinical programmes by 2030 focused on metabolic health, according to remarks at a Jefferies conference

ORIGINAL · NewsquawkZealand Pharma (ZEAL DC) targets 10 new clinical programmes by 2030 focused on metabolic health, according to remarks at a Jefferies conference
StockNow breaking-news AI analysis

Zealand Pharma reiterated a target of 10 metabolic-health clinical programmes by 2030, a goal its November 12 update linked to expanded research capabilities and a growing pipeline.

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more